Globitair

Definium Therapeutics Announces New Employee Inducement Grants

Financial PostUnited States of America

NEW YORK — Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to six newly hired non-executive employees consisting of options to purchase an aggregate of 93,320 common shares […]

Read the full story at Financial PostOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about United States of America